Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1275

AMG305-CDH3-hIgG1

Home » Antibodies » AMG305-CDH3-hIgG1

Background of AMG305-CDH3-hIgG1

AMG 305 is a pioneering BiTE® (bispecific T cell engager) molecule that simultaneously binds to both P-cadherin (CDH3) and mesothelin (MSLN) to exert potent cytotoxic effects. Immunohistochemistry analysis reveals that CDH3 and MSLN are co-expressed in various types of solid tumors. However, in normal tissues, immunostaining demonstrates a lower occurrence of overlapping co-expression compared to the expression of either one of the targets alone. AMG 305 employs an avidity-based mechanism to activate T cells, enabling them to selectively eliminate CDH3+MSLN+ tumor cells while displaying limited activity against normal cells expressing only one of the target antigens.

Specifications

Catalog Number:
KB-1275
Antibody Name:
AMG305-CDH3-hIgG1
Isotype:
Human IgG1,kappa
FC Muations:
Wild Type
Target:
CDH3
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
FACS
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. AMG 305, a dual targeting BiTE®molecule with selective activity for solid tumors that co-express CDH3 and MSLN